U.S. ASRs and RUOs Market Outlook 2031

  • The U.S. ASRs and RUOs market was valued over US$ 3.6 Bn in 2020
  • It is estimated to expand at a CAGR of 4.7% from 2021 to 2031
  • The U.S. ASRs and RUOs market is expected to surpass the value of US$ 5.3 Bn by the end of 2031

Analysts’ Viewpoint on U.S. ASRs and RUOs Market

Continuous R&D efforts to reduce morbidity and mortality associated with coronavirus has heightened the demand for diagnostic testing with ASRs & RUOs. The human healthcare segment was found to dominate the revenue share among all end-use applications in the market in 2020. This segment is estimated to register high market attractiveness index by 2031. The segment is anticipated to expand at high CAGR throughout the assessment period. The segment’s dominance can be attributed to increase the use of ASRs and RUOs in specific disease diagnosis, new product development, and increase in research & development activities. Even though the U.S. ASRs and RUOs market is positioned for healthy growth during the forecast period, stakeholders need to seek clarity about stringent regulations regarding commercially distributed ASRs. Hence, stakeholders in the U.S. ASRs and RUOs market should adhere to FDA guidelines and seek clarification of international healthcare organizations to bolster their credibility credentials.

Surge in In-vitro Diagnostic Applications Catalyzing Demand for ASRs

The increase in usage of ASRs (Analyte Specific Reagents) in diagnostic testing helps healthcare providers screen for or monitor specific diseases or conditions. It also helps assess patient health to make clinical decisions for patient care. Companies are increasing research in ASR adenovirus probe and ASR adenovirus primer that are used for in-vitro detection of human adenovirus (HAdV)-specific DNA with the help of real-time polymerase chain reaction (PCR).

Rise in usage of ASRs in various diagnostic applications is expected to boost the growth of the ASRs and RUOs market in the U.S. during the forecast period.

Request a sample to get extensive insights into the ASRs and RUOs Market

Increased Importance of Diagnostic Testing with ASRs During COVID-19

ASRs are playing an instrumental role in early development and regulation of diagnostic testing for COVID-19. Such findings are translating into revenue opportunities for healthcare stakeholders. Diagnostic testing is a critical part of the public health response and clinical management of COVID-19, the disease caused by the SARS-CoV-2 virus. In an effort to facilitate the expansion of testing capacity as the first cases of community spread were confirmed in the United States, the Food and Drug Administration (FDA) announced a new COVID 19 diagnostics policy. The new policy, issued via agency guidance and effective immediately, allowed certain laboratories that had developed & validated their own COVID-19 diagnostic to begin to use the test prior to receiving an Emergency Use Authorization (EUA) from the agency.

To understand how our report can bring difference to your business strategy, Ask for a brochure

Technological Advancements Help Boost Experiments with RUOs

ASRs are antibodies, both polyclonal and monoclonal, specific receptor proteins, ligands, nucleic acid sequences, and similar reagents, which, through specific binding or chemical reaction with substances in a specimen, are intended for use in a diagnostic application for identification & quantification of an individual chemical substance or ligand in biological specimens.

Research use only (RUO) means research that is not for profit, internal research, or research for evaluation purposes. Research use only specifically excludes using the product by the licensee in any activity for consideration. According to Transparency Market Research (TMR), the U.S. ASRs and RUOs market is projected to expand at a modest CAGR during the forecast period. Technological advancements are anticipated to drive the U.S. ASRs and RUOs market during the forecast period.

Stuck in a neck-to-neck competition with other brands? Request a custom report on ASRs and RUOs Market

Rise in Prevalence of Infectious Diseases Triggering Demand for ASRs

The U.S. ASRs and RUOs market has witnessed robust growth in the last decade. Technological developments in the field of biotechnology and life sciences are steering the growth of the market. Advancement in technology has expanded the application areas of biotechnology and life sciences, thereby fueling revenue growth of the U.S. ASRs and RUOs market.

The rise in prevalence of infectious diseases, cancer, and hereditary diseases is boosting the demand for diagnostic tools. The surge in use of diagnostic tools such as polymerase chain reaction, hematology, and immunoassay are augmenting the growth of the market.

Technological advancements in the field of cell and tissue culture has increased the usage of ASRs in the areas of microbiology, antibiotics, and diagnostic testing. Moreover, ongoing research & development (R&D) and increase in demand for innovative and breakthrough technologies are propelling income avenues in the U.S. ASRs and RUOs market.

Use of RUOs to Develop Medical Knowledge Related to Human Diseases

RUO means an in-vitro diagnostic product that is in the laboratory research phase of development and is being shipped or delivered for an investigation. Certain products, such as instruments, systems, and reagents, are considered under for research use only products segment.

These products are used to carry out research and not the object of the research. These include products intended for use in discovering and developing medical knowledge related to human diseases and conditions. For instance, instruments and reagents intended for use in research attempting to isolate a gene linked with a particular disease could be labeled for research use only when such instruments & reagents are not intended to produce results for clinical use.

U.S. ASRs and RUOs Market: Overview

  • Analyte specific reagents (ASR) are antibodies, both polyclonal and monoclonal, specific receptor proteins, ligands, nucleic acid sequences, and similar reagents which, through specific binding or chemical reaction with substances in a specimen, are intended for use in a diagnostic application for identification and quantification of an individual chemical substance or ligand in biological specimens.
  • Research use only (RUO) means research that is not for profit, internal research, or research for evaluation purposes. Research use only specifically excludes using the product by the licensee in any activity for consideration.
  • Technological advancements are anticipated to drive the ASRs and RUOs market in the U.S. during the forecast period

Technological Advancements: Key Driver

  • The ASRs and RUOs market in the U.S. has witnessed robust growth in the last decade. Technological developments in the field of biotechnology and life sciences drive the market in the country. Advancement in technology has expanded the application areas of biotechnology and life sciences, thereby fueling the growth of the ASRs and RUOs market.
  • Rise in prevalence of infectious diseases, cancer, and hereditary diseases increases the demand for diagnostic tools. Surge in use of diagnostic tools such as polymerase chain reaction (PCR), hematology, and immunoassay augments the market.
  • Technological advancements in the field of cell and tissue culture has increased the usage of ASRs in the areas of microbiology, antibiotics, and diagnostic testing. Moreover, ongoing research & development and increase in demand for innovative and breakthrough technologies propel the ASRs and RUOs market in the U.S.

Increase in Usage of ASRs in Diagnostic Applications: Major Driver

  • Increase in usage of ASRs in diagnostic testing helps health care providers screen for or monitor specific diseases or conditions. It also helps assess patient health to make clinical decisions for patient care.
  • For instance, altona diagnostics’s RealStar ASR Adenovirus Probe and the RealStar ASR Adenovirus Primer are analyte specific reagents (ASR) that are used for in vitro detection of human adenovirus (HAdV) specific DNA by real-time polymerase chain reaction (PCR)
  • Increase in usage of ASRs in various diagnostic applications is expected to boost the growth of the ASRs and RUOs market in the U.S. during the forecast period

Human Healthcare Segment to Lead U.S. ASRs and RUOs Market

  • The human healthcare segment dominated the market in 2020. The segment is projected to register high market attractiveness index by 2031. The segment is anticipated to expand at high CAGR from 2021 to 2031.
  • The segment’s dominance can be attributed to increase in use of ASRs and RUOs in specific disease diagnosis, new product development, and increase in research & development activities

Major Players

  • Key players operating in the ASRs and RUOs market in the U.S. include
    • BioLegend, Inc.
    • ELITechGroup
    • BD
    • bioMerieux, Inc.
    • Genetic Signatures
    • Thermo Fisher Scientific, Inc.
    • Danaher Corporation
    • DiaSorin Molecular LLC
    • LGC Biosearch Technologies
    • altona Diagnostics GmbH
    • QIAGEN
  • Each of these players has been profiled in the ASRs and RUOs market report based on parameters such as company overview, financial overview, business strategies, application portfolio, business segments, and recent developments

U.S. ASRs and RUOs Market Snapshot

Attribute

Detail

Market Size Value in 2020 (Base Year)

US$ 3.6 Bn

Market Forecast Value in 2031

US$ 5.3 Bn

Growth Rate (CAGR)

4.7%

Forecast Period

2017–2031

Quantitative Units

US$ Bn for Value

Market Analysis

It includes cross segment analysis at regional level. Moreover, qualitative analysis includes drivers, restraints, opportunities, key trends, pricing analysis, and parent industry overview.

Format

Electronic (PDF)

Market Segmentation

  • By Product Type
    • Analyte Specific Reagents
    • Research Use Only Products
  • By End-user by Application
    • Human Healthcare
    • Veterinary
    • Environmental
    • Food Industry
    • Academic & Research Institutes
    • Others

Companies Profiled

  • BioLegend, Inc.
  • ELITechGroup
  • BD
  • bioMerieux, Inc.
  • Genetic Signatures
  • Thermo Fisher Scientific, Inc.
  • Danaher Corporation
  • DiaSorin Molecular LLC
  • LGC Biosearch Technologies
  • altona Diagnostics GmbH
  • QIAGEN

Customization Scope

Available upon request

Pricing

Available upon request

Frequently Asked Questions

ASRs and RUOs market in U.S. to surpass the value of US$ 5.3 Bn by the end of 2031

ASRs and RUOs market in U.S. to expand at a CAGR of 4.7% from 2021 to 2031

ASRs and RUOs market in U.S. is driven by Rise in Usage of ASRs in Various Diagnostic Applications

The human healthcare segment dominated the U.S. ASRs and RUOs market and the trend is projected to continue during the forecast period

Key players in the ASRs and RUOs market in U.S. include BioLegend, Inc., ELITechGroup, BD, bioMerieux, Inc., Genetic Signatures, Thermo Fisher Scientific, Inc.

U.S. ASRs and RUOs Market – Scope of Report

TMR’s report on the ASRs and RUOs market in the U.S. studies the current as well as future prospects of the ASRs and RUOs market in the U.S. Stakeholders of the report include companies and intermediaries engaged in provision of ASRs and RUOs as well as new players planning to enter the market.

The report provides market value in terms of US$ Mn for the period from 2017 to 2031, along with the compound annual growth rate (CAGR %) from 2021 to 2031 are provided for all segments, considering 2020 as the base year and 2017–2019 as the historical years.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players’ product literature, annual reports, press releases, and relevant documents to understand the ASRs and RUOs market in the U.S.

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the ASRs and RUOs market in the U.S.

This report comprises an elaborate executive summary, along with a market snapshot providing overall information of various segments considered in the scope of the study. This section also provides the overall information and data analysis of the ASRs and RUOs market in the U.S. with respect to the leading market segments based on product type and end-user by application.

The ASRs and RUOs market in the U.S. has been studied based on major segments and their regional as well as national markets.

The report delves into the competition landscape of the ASRs and RUOs market in the U.S. Key players operating in the ASRs and RUOs market in the U.S. have been identified and each one of these is profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the ASRs and RUOs market in the U.S. profiled in this report.

Key Questions Answered in U.S. ASRs and RUOs Market Report

  • What is the sales/revenue generated by ASRs and RUOs suppliers/manufacturers across the U.S. during the forecast period?
  • What are the key trends in the ASRs and RUOs market in the U.S.?
  • What are the major drivers, restraints, opportunities, and threats in the market?
  • Which segment is set to expand at the fastest CAGR during the forecast period?
  • Which ASRs and RUOs segment will have the highest revenue in 2031 and which segment will grow at the highest CAGR during the forecast period?

U.S. ASRs and RUOs Market – Research Objectives and Research Approach

The comprehensive report on the ASRs and RUOs market in the U.S. begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.

The report analyzes the ASRs and RUOs market in the U.S. in terms of product type and end-user by application. Key segments under each criterion have been studied at length, and the market share for each of these at the end of 2031 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the ASRs and RUOs market in the U.S.

U.S. ASRs and RUOs Market – Segmentation

TMR’s study on the ASRs and RUOs market includes information divided into two segments: product type and end-user by application.

Product Type
  • Analyte Specific Reagents
  • Research Use Only Products
End-user by Application
  • Human Healthcare
  • Veterinary
  • Environmental
  • Food Industry
  • Academic & Research Institutes
  • Others

1. Preface

    1.1. Market Definition and Scope

    1.2. Market Segmentation

    1.3. Key Research Objectives

    1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: U.S. ASRs and RUOs Market

4. Market Overview

    4.1. Introduction

        4.1.1. Product Type Definition

        4.1.2. Industry Evolution / Developments

    4.2. Overview

    4.3. Market Dynamics

        4.3.1. Drivers

        4.3.2. Restraints

        4.3.3. Opportunities

    4.4. U.S. ASRs and RUOs Market Analysis and Forecast, 2017–2031

        4.4.1. Market Revenue Projections (US$ Mn)

5. Key Insights

    5.1. General Purpose Reagents Uses in Lab-developed Tests: Overview

    5.2. General Purpose Reagents Market: Federal Oversight of Diagnostic Tests

    5.3. Porters Five Forces Model

    5.4. Regulatory Scenario: U.S. ASRs and RUOs Market

    5.5. COVID-19 Pandemic Impact on Industry

6. U.S. ASRs and RUOs Market Analysis and Forecast, By Product Type

    6.1. Introduction & Definition

    6.2. Key Findings / Developments

    6.3. Market Value Forecast, by Product Type, 2017–2031

        6.3.1. Analyte Specific Reagents

        6.3.2. Research Use Only Products

    6.4. Market Attractiveness Analysis, By Product Type

7. U.S. ASRs and RUOs Market Analysis and Forecast, By End-user by Application

    7.1. Introduction & Definition

    7.2. Key Findings / Developments

    7.3. Market Value Forecast, by End-user by Application, 2017–2031

        7.3.1. Human Healthcare

        7.3.2. Veterinary

        7.3.3. Environmental

        7.3.4. Food Industry

        7.3.5. Academic & Research Institutes

        7.3.6. Others

    7.4. Market Attractiveness Analysis, By End-user by Application

8. Competition Landscape

    8.1. Competitive Business Strategies

    8.2. Company Profiles

        8.2.1. BioLegend, Inc.

            8.2.1.1. Company Description

            8.2.1.2. Business Overview

            8.2.1.3. Financial Overview

            8.2.1.4. Strategic Overview

            8.2.1.5. SWOT Analysis

        8.2.2. ELITechGroup

            8.2.2.1. Company Description

            8.2.2.2. Business Overview

            8.2.2.3. Financial Overview

            8.2.2.4. Strategic Overview

            8.2.2.5. SWOT Analysis

        8.2.3. BD

            8.2.3.1. Company Description

            8.2.3.2. Business Overview

            8.2.3.3. Financial Overview

            8.2.3.4. Strategic Overview

            8.2.3.5. SWOT Analysis

        8.2.4. bioMerieux, Inc.

            8.2.4.1. Company Description

            8.2.4.2. Business Overview

            8.2.4.3. Financial Overview

            8.2.4.4. Strategic Overview

            8.2.4.5. SWOT Analysis

        8.2.5. Genetic Signatures

            8.2.5.1. Company Description

            8.2.5.2. Business Overview

            8.2.5.3. Financial Overview

            8.2.5.4. Strategic Overview

            8.2.5.5. SWOT Analysis

        8.2.6. Thermo Fisher Scientific, Inc.

            8.2.6.1. Company Description

            8.2.6.2. Business Overview

            8.2.6.3. Financial Overview

            8.2.6.4. Strategic Overview

            8.2.6.5. SWOT Analysis

        8.2.7. Danaher Corporation

            8.2.7.1. Company Description

            8.2.7.2. Business Overview

            8.2.7.3. Financial Overview

            8.2.7.4. Strategic Overview

            8.2.7.5. SWOT Analysis

        8.2.8. DiaSorin Molecular LLC

            8.2.8.1. Company Description

            8.2.8.2. Business Overview

            8.2.8.3. Financial Overview

            8.2.8.4. Strategic Overview

            8.2.8.5. SWOT Analysis

        8.2.9. LGC Biosearch Technologies

            8.2.9.1. Company Description

            8.2.9.2. Business Overview

            8.2.9.3. Financial Overview

            8.2.9.4. Strategic Overview

            8.2.9.5. SWOT Analysis

        8.2.10. altona Diagnostics GmbH

            8.2.10.1. Company Description

            8.2.10.2. Business Overview

            8.2.10.3. Financial Overview

            8.2.10.4. Strategic Overview

            8.2.10.5. SWOT Analysis

        8.2.11. QIAGEN

            8.2.11.1. Company Description

            8.2.11.2. Business Overview

            8.2.11.3. Financial Overview

            8.2.11.4. Strategic Overview

            8.2.11.5. SWOT Analysis

List of Tables

Table 01: General Purpose Reagents Market: Federal Oversight of Diagnostic Tests

Table 02: U.S. ASRs and RUOs Market Value (US$ Mn) Forecast, by Product Type, 2017–2031

Table 03: U.S. ASRs and RUOs Market Value (US$ Mn) Forecast, by End-user by Application, 2017–2031

Table 04: U.S. ASRs and RUOs Market Value (US$ Mn) Forecast, by Human Healthcare, 2017–2031

Table 05: U.S. ASRs and RUOs Market Value (US$ Mn) Forecast, by Veterinary, 2017–2031

Table 06: U.S. ASRs and RUOs Market Value (US$ Mn) Forecast, by Environmental, 2017–2031

Table 07: U.S. ASRs and RUOs Market Value (US$ Mn) Forecast, by Food Industry, 2017–2031

Table 08: U.S. ASRs and RUOs Market Value (US$ Mn) Forecast, by Academic & Research Institutes, 2017–2031

List of Figures

Figure 01: U.S. ASRs and RUOs Market Value (US$ Mn) Forecast, 2017–2031

Figure 02: U.S. ASRs and RUOs Market Value Share, by Product Type, 2020

Figure 03: U.S. ASRs and RUOs Market Value Share, by End-user by Application, 2020

Figure 04: U.S. General Purpose Reagents Market Value (US$ Mn) Forecast, 2017–2031

Figure 05: Total Number of Covid-19 Cases by Highly Impacted States in U.S.

Figure 06: Confirmed Total Cases in Different Countries (2020)

Figure 07: Cumulative Total Confirmed & Death Cases Across Countries

Figure 08: Total Recovered Cases Across Countries (2020)

Figure 09: U.S. ASRs and RUOs Market Value Share Analysis, by Product Type , 2020 and 2031

Figure 10: U.S. ASRs and RUOs Market Attractiveness Analysis, by Product Type, 2021–2031

Figure 11: U.S. ASRs and RUOs Market Revenue (US$ Mn), by Analyte Specific Reagents, 2017–2031

Figure 12: U.S. ASRs and RUOs Market Revenue (US$ Mn), by Research Use Only Products, 2017–2031

Figure 13: U.S. ASRs and RUOs Market Value Share Analysis, by End-user by Application, 2020 and 2031

Figure 14: U.S. ASRs and RUOs Market Attractiveness Analysis, by End-user by Application, 2021–2031

Figure 15: U.S. ASRs and RUOs Market Revenue (US$ Mn), by Human Healthcare, 2017–2031

Figure 16: U.S. ASRs and RUOs Market Revenue (US$ Mn), by Veterinary, 2017–2031

Figure 17: U.S. ASRs and RUOs Market Revenue (US$ Mn), by Environmental, 2017–2031

Figure 18: U.S. ASRs and RUOs Market Revenue (US$ Mn), by Food Industry, 2017–2031

Figure 19: U.S. ASRs and RUOs Market Revenue (US$ Mn), by Academic & Research Institutes, 2017–2031

Figure 20: U.S. ASRs and RUOs Market Revenue (US$ Mn), by Others, 2017–2031

Custom Market Research Services

TMR offers custom market research services that help clients to get information on their business scenario required where syndicated solutions are not enough.

Request Customization